<DOC>
	<DOCNO>NCT01686776</DOCNO>
	<brief_summary>This prospective , validation study extempore make tracer compare commercial . Studies tracer medical effect use study human physiology , case pharmacokinetic variable endogenous albumin distribution turnover different level inflammation . 1 . Primary Objective : - Do extempore make tracer 123-iodine labeled albumin commercially manufacture SERALB-125 give identical value calculate blood plasma volume capillary leakage measure transcapillary escape rate albumin ? 2 . Secondary Objective : - How three different measure albumin turnover correlate volunteer ? - How pharmacokinetic parameter endogenous albumin vary three study group ?</brief_summary>
	<brief_title>A Prospective Validation Study Albumin Kinetics With Tracer 123 I-HSA</brief_title>
	<detailed_description />
	<criteria>healthy volunteer ( treatment arm I ) contraceptive agent and/or contraceptive device visual peripheral vein sign informed consent plan elective large interabdominal surgery ( treatment arm II ) patient acute pancreatitis cholecystitis ( treatment arm III ) pregnant woman and/or lactate allergy towards excipients 123 I HSA 125 I HSA participate another study involve radiation stabile isotope within period 60 day study start opinion principle investigator patient/subject participate his/hers good</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2013</verification_date>
	<keyword>Plasma albumine</keyword>
	<keyword>Plasma volume</keyword>
	<keyword>Transcapillary escape rate</keyword>
	<keyword>Inflammation</keyword>
	<keyword>Circulation</keyword>
</DOC>